Tango Therapeutics, Inc. (TNGX) Net income 2020–2025
Tango Therapeutics, Inc. (TNGX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$101.6MFY2025 · since FY2020: -$52.0M → -$101.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$101.6M | +22.0% |
| FY2024 | -$130.3M | -28.1% |
| FY2023 | -$101.7M | +6.0% |
| FY2022 | -$108.2M | -85.8% |
| FY2021 | -$58.2M | -12.1% |
| FY2020 | -$52.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice